Project Grant R01CA300353
Award Date 5/12/26
Completion Date 4/30/31
Dollars Obligated $605K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
- Federal Project Grant Award Summary The National Cancer Institute awarded The Johns Hopkins University a $354,658 Project Grant under the Cancer Biology Research program (CFDA 93.396) effective August 1, 2025 through July 31, 2030. This award supports fundamental research investigating subclonal P27 (CDKN1B) loss as a driver of aggressive prostate cancer, with particular focus on understanding health disparities affecting Black or African American males who experience prostate cancer mortality...
- Federal Grant Award Summary The National Cancer Institute awarded The Johns Hopkins University a Project Grant of $130,301 under the Cancer Cause and Prevention Research program (CFDA 93.393), with an award date of September 5, 2025, and a project completion date of August 31, 2030. This award supports extensions to the Surveillance, Epidemiology, and End Results (SEER)-Medicare Database, a critical data linkage that connects Medicare claims with cancer registry enrollment data. The primary...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Johns Hopkins University a $512,728 Project Grant effective August 1, 2025, through May 31, 2030, under the Cancer Detection and Diagnosis Research Program (CFDA 93.394). The award supports development and clinical evaluation of PROBOT, a novel ultrasound probe and robotic system designed to improve image-guided interventions for prostate cancer diagnosis and treatment. The project encompasses a Phase 1...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Trustees of Columbia University in the City of New York a Project Grant of $531,825 under the Cancer Biology Research program (CFDA 93.396) effective August 1, 2025, with completion targeted for July 31, 2030. This research initiative focuses on understanding the molecular mechanisms of castration sensitivity in prostate epithelium, with the ultimate goal of improving therapeutic responses to androgen-deprivation therapy...
- Federal Grant Award Summary The National Cancer Institute awarded The Washington University a $160,093 Project Grant effective May 1, 2026, through April 30, 2028, under the Cancer Cause and Prevention Research program (CFDA 93.393). The grant supports research investigating perceptions and informational needs regarding risk-based prostate cancer screening among screening-eligible men. The research addresses disparities in prostate-specific antigen (PSA) screening practices, particularly among...
- Project Grant Summary Georgetown University received a $663,383 Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) on August 1, 2025, to support proactive outreach and streamlined genetic testing initiatives for prostate cancer survivors. The project, extending through July 31, 2030, addresses the critical gap between expanded germline genetic testing guidelines and low testing rates among the nation's over three million...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pittsburgh a $649,620 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) effective May 1, 2026, through April 30, 2031. This research project examines the impacts of Medicare Advantage insurance coverage on cancer care access, quality, and outcomes for older adults with the four most prevalent cancers: breast, colorectal, lung, and prostate. The research addresses a...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Johns Hopkins University a Project Grant totaling $144,193 under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) on September 4, 2025, with a completion date of August 31, 2030. This award provides protected salary support for Dr. Preethi Korangath, a Laboratory Research Specialist in Dr. Robert Ivkov's laboratory, to advance research in cancer detection and treatment technologies. Dr. Korangath will...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a $679,290 Project Grant to the University of California, San Francisco (UCSF) under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) to develop and translate novel hyperpolarized (HP) carbon-13 dual-agent magnetic resonance imaging (MRI) technologies for improved prostate cancer diagnosis and biopsy guidance. The award, effective April 1, 2026, through March 31, 2031, supports research designed to...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Oklahoma Health Sciences Center a $592,731 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) beginning May 15, 2026, and concluding April 30, 2031. This award supports a randomized controlled trial to improve prostate cancer screening among Black men in Oklahoma through development and validation of the Prostate Cancer Genius App (PCGA), a smartphone-based mobile health...